The 19th Director of the U.S. CDC, Rochelle P. Walensky, M.D., M.P.H., issued a statement today endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation for a booster shot of the Pfizer-BioNTech COVID-19 vaccine in specific populations.
Dr. Walensky also recommended a booster dose for those in high-risk occupational and institutional settings.
CDC Director Issues Interim 3rd COVID-19 Vaccine Guidance
Antibodies ID’d in Neonates of Women Vaccinated Against COVID-19
All 36 neonates had high levels of anti-S IgG; in 34 of 36 neonates, levels exceeded 250 U/mL
Past Trauma Tied to Worse Mental Health During Pandemic for Aging Women
History of childhood abuse or intimate partner violence linked to greater depression, anxiety, and sleep problems during COVID-19 pandemic
WHO Issues Guidance for Use of Casirivimab-Imdevimab in COVID-19
Combo conditionally recommended for patients with nonsevere disease at risk for severe disease, seronegative patients with severe infection
CDC Endorses Booster Shots for Millions of Americans
Recommendations came just one day after the FDA authorized boosters for several vulnerable groups at least six months after the second dose
FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans
Exactly who qualifies as high risk because of health or work reasons is not yet clear
Emergency Help for Suicide-Related Issues Up During Pandemic for Some Youth
Rates higher for female youth, those with no psychiatric history, and individuals with existing psychiatric diagnoses at time of encounter
Newborns Benefit From COVID-19 Vaccinated Mothers
A limited study conducted by NYU Langone Health found pregnant women who receive an mRNA COVID-19 vaccine during pregnancy passed high levels of antibodies to their babies.
Existing studies analyzed antibodies to the spike protein (anti-S IgG) alone, which may be present after natural infection or vaccination, and do not include antibodies to the nucleocapsid protein (anti-N IgG), which is only present following natural infection.
How Long Does Immunity Last in COVID-19 Vaccinated People
California-based La Jolla Institute for Immunology (LJI) scientists’ new study helps answer the question: how long does immunity against COVID-19 last in vaccinated people?
As reported in the journal Science on September 14, 2021, a low dose of the Moderna, Inc. vaccine known as SpikeVax, immunity lasts for at least six months.
And no indicator vaccinated people will need a booster shot from this mRNA vaccine.
Uptake Low for Monoclonal Antibodies for COVID-19
Use peaked in January and declined in early 2021, at the time of the vaccine rollout